KAT6A and KAT6B Symposium 2022
March 23rd, 7:00 AM - 10:00 AM (Australian, EST)
March 22nd, 2022, 04:00 PM - 7:00 PM (US, EST)
March 22nd, 2022, 08:00 PM - 11:00 PM (GMT)
June 15-19, The Venue Center, NYC
What the KAT6A/B Symposium Is All About
Purpose
The KAT6A & KAT6B Virtual Symposium series is an initiative led by the KAT6A Foundation, designed to support patients and their families living with KAT6A and KAT6B related disorders.
The symposium aims to solidify current KAT6A & KAT6B research network amongst clinicians and researchers through identification of research opportunities and ongoing collaborations.
By enabling a space that facilitates open dialogue in order to share resources, ideas and tools, the symposium also aims to spark new collaboration amongst researchers and health care professionals interested in KAT6A/B disorders.
The 2021 KAT6A & KAT6B symposium was the first collaborative research event organised by the KAT6A Foundation. Over 45 participants attended the virtual meeting which included 16 speakers invited to present their research related to KAT6A or KAT6B genes. In this meeting, domains of speech, language and communication were identified as significant health challenges by the KAT6A and KAT6B community. The upcoming KAT6A & KAT6B symposium will focus on bringing together the speech and language experts working on rare genetic conditions and foster their connection with the foundation and families who have a child with KAT6A or KAT6B gene variation.
Meet the Team
.jpg)
Natacha Esber
Science and Research Director, KAT6A Foundation
Meg Salisbury
Board of Director
KAT6A Foundation
Jordan Muller
Chairperson
KAT6A Foundation
David J Amor
Group Leader, Neurodisability and Rehabilitation
Murdoch Children's Research Institute, Australia
Emile Najm
CEO, KAT6A Foundation
.png)
Andrew Rankin
Board of Director
KAT6A Foundation
Bhawika Sharma L.
Postdoctoral Researcher
University of Utah, USA
Angie Serrano
Scientific Advisor, KAT6A Foundation
Tanya Tripathi
Research Coordinator, KAT6A Foundation
Session Chair
Angela Morgan
Group Leader, Speech and Language
Murdoch Children's Research Institute, Australia
Speakers
Ying Weng
Assistant Professor,
Tongji Hospital, China
Miya St John
Speech Pathologist and PhD Candidate
Murdoch Children's Research Institute, Australia
Frederique Liegeois
Associate Professor, Developmental Neurosciences Dept.
University College London
Marc Seal
Group Leader, Clinical Sciences
Murdoch Children's Research Institute, Australia
Anne Voss
Joint-Divison Head, Epigenetics and Development Division
Walter and Eliza Hall Institute of Medical Research, Australia
Simon E Fisher
Director, Max Planck Institute of Psycholinguistics, Netherlands
Kate Baker
Programme Leader, MRC Cognition and Brain Sciences Unit, University of Cambridge, UK
Emma Baker
Post doctoral Research Officer, Murdoch Children's Research Institute, Australia
Patricia Wilson
Speech Language Pathologist at Otto Specht School, USA
Typhaine Lejeune
Member of the KAT6A Foundation
Canada
Opening Remarks by Natacha Esber
07:00 AM (AEST)
Session 1: KAT6A Foundation - Empowering Patient-centered Research and Collaboration
07:05 AM - 07:20 AM (AEST)
KAT6A Foundation's Plan for 2022
Speaker: Emile Najm and Jordan Muller, KAT6A Foundation
KAT6A Foundations Research Collaborations
Speaker: Ying Weng, Tongji Hospital, China
Session 2: Understanding the pathophysiology of KAT6A and KAT6B related speech and language disorders
07:30 AM - 09:55 AM (AEST)
Chair: Angela Morgan
Panel Members: David Amor, Angie Serrano and Natacha Esber
Distinguish speech from language.
Understand the spectrum of speech and language in KAT6A gene variations.
Speaker: Miya St John, Murdoch Children's Research Institute, Australia
Neuroimaging in KAT6A and KAT6B related disorders
Feasibility of using sophisticated quantitative MRI techniques to understand the impact of variation in KAT6A or KAT6B genes on speech and language pathways
Speakers: Frederique Liegeois, University College of London, UK
Marc Seal, Murdoch Children's Research Institute, Australia
Neurological markers of speech and language impairments in rare genetic disorders.
Speakers: Simon E Fisher, Radbound University, Netherlands
Kate Baker, University of Cambridge, UK
Animal models in speech and language research
Speaker: Anne Voss, Walter and Eliza Institute of Medical Research, Australia
Neuropsychological assessment of kids with apraxia
Speaker: Emma Baker, Murdoch Children's Research Institute, Australia
Pathways to treat children with apraxia
Speech therapist perspective on rare genetic disorders.
Speaker: Patricia Wilson, Otto Specht School, USA
Parent perspective on navigating speech, language and communication challenges in children with rare genetic variation
Speaker: Typhaine Lejeune, Parent of a child with KAT6B gene variation and Member of the KAT6A Foundation
Panel discussion
Moderators - Angela Morgan, David Amor and Natacha Esber
